These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4978575)

  • 1. [A study of the antigenic composition of various strains of the tularemia microbe. II. Comparative antigenic composition of a virulent and avirulent microbe].
    Sukhar' VV
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Aug; 43(8):104-8. PubMed ID: 4978575
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic structure of tularemia microbe strains with different degrees of virulence.
    Meshcheryakova IS
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(4):446-56. PubMed ID: 4992903
    [No Abstract]   [Full Text] [Related]  

  • 3. Virulence factors of Francisella tularensis.
    Hood AM
    J Hyg (Lond); 1977 Aug; 79(1):47-60. PubMed ID: 267668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron microscopy study of the localization of antigens in virulent and an avirulent strain of Francisella tularensis, using mercury-labelled antibodies.
    Mesheryakova IC; Katz LN; Pavlova IB; Kulberg AY
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(2):147-50. PubMed ID: 5629468
    [No Abstract]   [Full Text] [Related]  

  • 5. Electron-microscopic study of localization of antigens in Francisella tularensis by means of ferritin-labelled antibodies.
    Kats IN; Meshcheryakova IS; Oghievetskaya MM
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(4):457-63. PubMed ID: 4099755
    [No Abstract]   [Full Text] [Related]  

  • 6. [The C antigen of Francisella tularensis].
    Sukhar' VV; Uraleva VS
    Mikrobiol Zh (1978); 1992; 54(2):42-6. PubMed ID: 1374833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Species- and genus-specific antigenic epitopes of Francisella tularensis lipopolysaccharides].
    Pavlovich NV; Aronova NV; Onoprienko NN; Sorokin VM; Mazrukho BL
    Mol Gen Mikrobiol Virusol; 2000; (3):7-12. PubMed ID: 10975073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antibody neutralization test in tularemia].
    Meshcheriakova IS; Emel'ianova OS
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):43-8. PubMed ID: 5735231
    [No Abstract]   [Full Text] [Related]  

  • 9. [A study of the antigenic composition of some strains of P. tularensis. I].
    Sukhar' VV
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Nov; 42(11):38-43. PubMed ID: 4960676
    [No Abstract]   [Full Text] [Related]  

  • 10. [The capacity of avirulent forms of Francisella tularensis for dissemination and proliferation in the host body].
    Tsimbalistova MV; Pavlovich NV; Sorokin VM; Tynkevich NK
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):10-3. PubMed ID: 8701638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunochemical characteristics of 2 geographic strains of tularemia microbes].
    Rodionova IV; Shipitsina GK
    Biokhimiia; 1967; 32(6):1161-8. PubMed ID: 4969633
    [No Abstract]   [Full Text] [Related]  

  • 12. Virulence determinants and protective antigens of Francisella tularensis.
    Sjöstedt A
    Curr Opin Microbiol; 2003 Feb; 6(1):66-71. PubMed ID: 12615222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytopathic effect of the tularemia microbe on a culture of peritoneal macrophages].
    Maslova TN; Savel'eva RA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):104-7. PubMed ID: 562567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antigenic and immunologic interrelationships between brucellae and the agents of tularemia].
    Parnas Iu
    Zh Mikrobiol Epidemiol Immunobiol; 1967 May; 44(5):60-2. PubMed ID: 4979510
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential Substrate Usage and Metabolic Fluxes in
    Chen F; Rydzewski K; Kutzner E; Häuslein I; Schunder E; Wang X; Meighen-Berger K; Grunow R; Eisenreich W; Heuner K
    Front Cell Infect Microbiol; 2017; 7():275. PubMed ID: 28680859
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral human γδ T cells control growth of both avirulent and highly virulent strains of Francisella tularensis in vitro.
    Rowland CA; Hartley MG; Flick-Smith H; Laws TR; Eyles JE; Oyston PC
    Microbes Infect; 2012 Jul; 14(7-8):584-9. PubMed ID: 22370220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
    Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
    Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence comparison in mice of distinct isolates of type A Francisella tularensis.
    Twine SM; Shen H; Kelly JF; Chen W; Sjöstedt A; Conlan JW
    Microb Pathog; 2006 Mar; 40(3):133-8. PubMed ID: 16448801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The glycolipid composition of Francisella tularensis strains with different degrees of attenuation].
    Sukhar' VV
    Mikrobiol Zh (1978); 1993; 55(1):8-12. PubMed ID: 8446062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.